Currently, Janux Therapeutics Inc’s (JANX) stock is trading at $13.73, marking a fall of -2.73% from last night’s close. At this price, the stock is -71.13% below its 52-week high of $47.58 and 3.58% above its 52-week low of $13.26.
As well, it is important to consider JANX stock ratios such as price-to-sales, which is currently 82.61.JANX’s price to book ratio for the most recent quarter was 0.85, resulting in an 0.84 price to cash per share for the period.
How does Janux Therapeutics Inc (JANX) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Janux Therapeutics Inc (JANX): Earnings History
If we examine Janux Therapeutics Inc’s recent earnings history, in the last quarter ended on 9/30/2025, it posted adjusted earnings per share of -$0.39, slashing the consensus of -$0.61. In other words, it beat the consensus by $0.22, resulting in a 36.30% surprise. In the 3 months period before the previous quarter which was closed on 9/30/2025, the stock recorded adjusted earnings per share of -$0.39 in contrast with the Outlook of -$0.61. That was a difference of $0.22 and a surprise of 36.30%.
Janux Therapeutics Inc (NASDAQ: JANX) Ownership Details
I will give a breakdown of the key shareholders in Janux Therapeutics Inc (JANX). Recent figures show that the company’s insiders hold 6.91% of shares. A total of 266 institutional investors hold shares in the company, making 110.22% of its stock and 118.41% of its float.
Sep 30, 2025, it was reported that the Company’s largest institutional holder is RA Capital Management, L.P. holding total of 11.19 shares that make 18.60% of the company’s total number of shares and are currently priced at 152.18 million.
The securities firm FMR, LLC holds 9.06 shares of JANX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 15.06%, and the holding percentage of shares is valued at 123.16 million.
